These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 19602051)
1. PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's disease. Morel M; Couturier J; Lafay-Chebassier C; Paccalin M; Page G J Cell Mol Med; 2009 Aug; 13(8A):1476-88. PubMed ID: 19602051 [TBL] [Abstract][Full Text] [Related]
2. Evidence of molecular links between PKR and mTOR signalling pathways in Abeta neurotoxicity: role of p53, Redd1 and TSC2. Morel M; Couturier J; Pontcharraud R; Gil R; Fauconneau B; Paccalin M; Page G Neurobiol Dis; 2009 Oct; 36(1):151-61. PubMed ID: 19631745 [TBL] [Abstract][Full Text] [Related]
3. PKR, a cognitive decline biomarker, can regulate translation via two consecutive molecular targets p53 and Redd1 in lymphocytes of AD patients. Damjanac M; Page G; Ragot S; Laborie G; Gil R; Hugon J; Paccalin M J Cell Mol Med; 2009 Aug; 13(8B):1823-1832. PubMed ID: 19210572 [TBL] [Abstract][Full Text] [Related]
4. Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer's disease. Paccalin M; Pain-Barc S; Pluchon C; Paul C; Besson MN; Carret-Rebillat AS; Rioux-Bilan A; Gil R; Hugon J Dement Geriatr Cogn Disord; 2006; 22(4):320-6. PubMed ID: 16954686 [TBL] [Abstract][Full Text] [Related]
5. The PKR/P38/RIPK1 Signaling Pathway as a Therapeutic Target in Alzheimer's Disease. Hugon J; Paquet C Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808629 [TBL] [Abstract][Full Text] [Related]
6. Upstream signaling pathways leading to the activation of double-stranded RNA-dependent serine/threonine protein kinase in beta-amyloid peptide neurotoxicity. Suen KC; Yu MS; So KF; Chang RC; Hugon J J Biol Chem; 2003 Dec; 278(50):49819-27. PubMed ID: 12975376 [TBL] [Abstract][Full Text] [Related]
7. PKR involvement in Alzheimer's disease. Hugon J; Mouton-Liger F; Dumurgier J; Paquet C Alzheimers Res Ther; 2017 Oct; 9(1):83. PubMed ID: 28982375 [TBL] [Abstract][Full Text] [Related]
9. Interaction of double-stranded RNA-dependent protein kinase (PKR) with the death receptor signaling pathway in amyloid beta (Abeta)-treated cells and in APPSLPS1 knock-in mice. Couturier J; Morel M; Pontcharraud R; Gontier V; Fauconneau B; Paccalin M; Page G J Biol Chem; 2010 Jan; 285(2):1272-82. PubMed ID: 19889624 [TBL] [Abstract][Full Text] [Related]
10. PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesions. Tible M; Mouton Liger F; Schmitt J; Giralt A; Farid K; Thomasseau S; Gourmaud S; Paquet C; Rondi Reig L; Meurs E; Girault JA; Hugon J Aging Cell; 2019 Jun; 18(3):e12887. PubMed ID: 30821420 [TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and promising therapeutics of Alzheimer disease through eIF2α pathway and correspondent kinases. Moradi Majd R; Mayeli M; Rahmani F Metab Brain Dis; 2020 Dec; 35(8):1241-1250. PubMed ID: 32681467 [TBL] [Abstract][Full Text] [Related]
12. The PKR activator PACT is induced by Aβ: involvement in Alzheimer's disease. Paquet C; Mouton-Liger F; Meurs EF; Mazot P; Bouras C; Pradier L; Gray F; Hugon J Brain Pathol; 2012 Mar; 22(2):219-29. PubMed ID: 21790829 [TBL] [Abstract][Full Text] [Related]
14. [Research Advances in the Association Between Alzheimer's Disease and Double-Stranded RNA-Dependent Protein Kinase]. Gong Y; Xiao XY; Hu YS; Xie YW; Wu ZH Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Jun; 46(3):425-434. PubMed ID: 38953267 [TBL] [Abstract][Full Text] [Related]
15. Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway. Mouton-Liger F; Paquet C; Dumurgier J; Bouras C; Pradier L; Gray F; Hugon J Biochim Biophys Acta; 2012 Jun; 1822(6):885-96. PubMed ID: 22306812 [TBL] [Abstract][Full Text] [Related]
16. Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice. Peel AL; Bredesen DE Neurobiol Dis; 2003 Oct; 14(1):52-62. PubMed ID: 13678666 [TBL] [Abstract][Full Text] [Related]
17. Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. Chang RC; Suen KC; Ma CH; Elyaman W; Ng HK; Hugon J J Neurochem; 2002 Dec; 83(5):1215-25. PubMed ID: 12437593 [TBL] [Abstract][Full Text] [Related]
18. Restoring synaptic plasticity and memory in mouse models of Alzheimer's disease by PKR inhibition. Hwang KD; Bak MS; Kim SJ; Rhee S; Lee YS Mol Brain; 2017 Dec; 10(1):57. PubMed ID: 29233183 [TBL] [Abstract][Full Text] [Related]
19. Protopanaxadiol derivative DDPU improves behavior and cognitive deficit in AD mice involving regulation of both ER stress and autophagy. Guo X; Lv J; Lu J; Fan L; Huang X; Hu L; Wang J; Shen X Neuropharmacology; 2018 Mar; 130():77-91. PubMed ID: 29197516 [TBL] [Abstract][Full Text] [Related]
20. The interferon-induced double-stranded RNA-activated protein kinase PKR will phosphorylate serine, threonine, or tyrosine at residue 51 in eukaryotic initiation factor 2alpha. Lu J; O'Hara EB; Trieselmann BA; Romano PR; Dever TE J Biol Chem; 1999 Nov; 274(45):32198-203. PubMed ID: 10542257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]